Physicians' Academy for Cardiovascular Education

Reshaping the future of heart failure management - Translating innovations to practice in HFpEF

Meeting report with presentation slides and video of a PACE-CME symposium held during Heart Failure 2019 in Athens on novel insights in the management of HFpEF.

Understanding and managing obesity-related HFpEF

10' education - July 22, 2019 - Milton Packer, MD
During the last 30 years, clinical characteristics of HF patients have changed; nowadays, obesity is common in HF. Dr. Packer explains why obesity plays such an important role in HFpEF.

During the last 30 years, clinical characteristics of HF patients have changed; nowadays, obesity is common in HF. Dr. Packer explains why obesity plays such an important role in HFpEF.

Cardiac amyloidosis: an emerging target in HFpEF?

10' education - July 19, 2019 - Prof. van der Meer, MD, PhD
Based on a case description, prof. van der Meer explains how to diagnose HFpEF based on amyloidosis. Futhermore, he talks about current and future treatments options for patients with transthyretin amyloid cardiomyopathy.

Based on a case description, prof. van der Meer explains how to diagnose HFpEF based on amyloidosis. Futhermore, he talks about current and future treatments options for patients with transthyretin amyloid cardiomyopathy.

Heart failure and diabetes: What is the goal of treatment?

10' education - July 17, 2019 - Prof. John McMurray, MD
Prof. McMurray gives an update on where we are today in the prevention of HF in diabetes patients with new diabetes drugs and talks about the next steps of treating HF in patients with and without diabetes.

Prof. McMurray gives an update on where we are today in the prevention of HF in diabetes patients with new diabetes drugs and talks about the next steps of treating HF in patients with and without diabetes.

Slides: Heart failure & diabetes: What is the goal of treatment?

Slides (presentation) - June 17, 2019 - Athens, Greece - John McMurray , MD - Glasgow, United Kingdom - PACE-CME symposium held during Heart failure 2019
This lecture by prof. John McMurray was part of a CME-accredited symposium

Slides as educational service to PACE members and meeting participants

Slides: Cardiac amyloidosis: An emerging target in HFpEF

Slides (presentation) - June 17, 2019 - Athens, Greece - Peter van der Meer, MD - Groningen, The Netherlands - PACE-CME symposium held during Heart failure 2019
This lecture by prof. Peter van der Meer was part of a CME-accredited symposium

Slides as educational service to PACE members and meeting participants

Slides: Understanding and managing obesity-related HFpEF

Slides (presentation) - June 17, 2019 - Athens, Greece - Milton Packer, MD - Dallas, TX, USA - PACE-CME symposium held during Heart failure 2019
This lecture by prof. Milton Packer was part of a CME-accredited symposium

Slides as educational service to PACE members and meeting participants

Reshaping the future of heart failure management - Translating innovations to practice in HFpEF

10' Education

Understanding and managing obesity-related HFpEF

10' education - July 22, 2019 - Milton Packer, MD

Cardiac amyloidosis: an emerging target in HFpEF?

10' education - July 19, 2019 - Prof. van der Meer, MD, PhD

Heart failure and diabetes: What is the goal of treatment?

10' education - July 17, 2019 - Prof. John McMurray, MD

Presentation Slides

Slides: Heart failure & diabetes: What is the goal of treatment?

Slides (presentation) - June 17, 2019 - Athens, Greece - John McMurray , MD - Glasgow, United Kingdom - PACE-CME symposium held during Heart failure 2019

Slides: Cardiac amyloidosis: An emerging target in HFpEF

Slides (presentation) - June 17, 2019 - Athens, Greece - Peter van der Meer, MD - Groningen, The Netherlands - PACE-CME symposium held during Heart failure 2019

Slides: Understanding and managing obesity-related HFpEF

Slides (presentation) - June 17, 2019 - Athens, Greece - Milton Packer, MD - Dallas, TX, USA - PACE-CME symposium held during Heart failure 2019